We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$391M
AUM Growth
+$24.9M
Cap. Flow
+$6.5M
Cap. Flow %
1.66%
Top 10 Hldgs %
24.49%
Holding
285
New
24
Increased
110
Reduced
87
Closed
16
Avg Time Held Equity + Options
14 quarters
Top 10 Avg Time Held Equity + Options
10.8 quarters
Top 20 Avg Time Held Equity + Options
12.8 quarters
Avg Time Held Equity only
14 quarters
Top 10 Avg Time Held Equity only
10.8 quarters
Top 20 Avg Time Held Equity only
12.8 quarters

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$3.14M
2
META icon
Meta Platforms (Facebook)
META
+$1.99M
3
NVDA icon
NVIDIA
NVDA
+$1.87M
4
AMZN icon
Amazon
AMZN
+$1.54M
5
GILD icon
Gilead Sciences
GILD
+$1.47M

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.37%
2 Technology 20.82%
3 Consumer Discretionary 13.26%
4 Financials 10.08%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MKL icon
176
Markel Group
MKL
$22.2B
$565K 0.14%
360
– –
2020 Q4
15 quarters
RELY icon
177
Remitly
RELY
$5.03B
$564K 0.14%
42,150
-5,800
-12% -$78.7K
2022 Q2
9 quarters
SRTA icon
178
Strata Critical Medical Inc
SRTA
$394M
$558K 0.14%
189,700
-7,850
-4% -$25K
2022 Q2
9 quarters
VGK icon
179
Vanguard FTSE Europe ETF
VGK
$29.4B
$550K 0.14%
7,740
-760
-9% -$52.3K
2020 Q3
16 quarters
CNC icon
180
Centene
CNC
$34B
$529K 0.14%
7,024
– –
2020 Q3
16 quarters
DBC icon
181
Invesco DB Commodity Index Tracking Fund
DBC
$1.98B
$522K 0.13%
23,450
+2,000
+9% +$44.7K
2023 Q1
6 quarters
O icon
182
Realty Income
O
$52B
$520K 0.13%
8,199
+36
+0.4% +$2.14K
2023 Q3
4 quarters
RH icon
183
RH
RH
$2.19B
$500K 0.13%
1,495
-450
-23% -$124K
2024 Q1
2 quarters
APD icon
184
Air Products & Chemicals
APD
$64.3B
$496K 0.13%
1,665
+305
+22% +$83.4K
2024 Q1
2 quarters
DOCU icon
185
DocuSign
DOCU
$13.5B
$495K 0.13%
7,977
-795
-9% -$44.6K
2020 Q4
15 quarters
NVS icon
186
Novartis
NVS
$271B
$490K 0.13%
4,261
-81
-2% -$9.19K
2016 Q4
31 quarters
RLAY icon
187
Relay Therapeutics
RLAY
$3.8B
$479K 0.12%
67,675
– –
2020 Q4
15 quarters
MDB icon
188
MongoDB
MDB
$30.1B
$468K 0.12%
1,730
+200
+13% +$52K
2024 Q2
1 quarter
GVIP icon
189
Goldman Sachs Hedge Industry VIP ETF
GVIP
$579M
$458K 0.12%
3,828
– –
2019 Q1
22 quarters
BTC icon
190
Grayscale Bitcoin Mini Trust ETF
BTC
$4.41B
$451K 0.12%
+16,017
New +$427K
2024 Q3
0 quarters
STZ icon
191
Constellation Brands
STZ
$21.5B
$446K 0.11%
1,729
-125
-7% -$31K
2019 Q1
22 quarters
ENVX icon
192
Enovix
ENVX
$551M
$441K 0.11%
53,943
+9,429
+21% +$97.9K
2024 Q1
2 quarters
SPOT icon
193
Spotify
SPOT
$108B
$439K 0.11%
1,191
-63
-5% -$20.9K
2020 Q4
15 quarters
CVS icon
194
CVS Health
CVS
$112B
$425K 0.11%
6,751
– –
2016 Q4
31 quarters
STNE icon
195
StoneCo
STNE
$2.72B
$416K 0.11%
36,975
-5,850
-14% -$74.6K
2018 Q4
23 quarters
UHAL icon
196
U-Haul Holding Co
UHAL
$10.8B
$414K 0.11%
5,340
+275
+5% +$18.8K
2023 Q2
5 quarters
DELL icon
197
Dell
DELL
$364B
$397K 0.1%
3,350
+500
+18% +$58.2K
2024 Q2
1 quarter
CME icon
198
CME Group
CME
$100B
$396K 0.1%
+1,796
New +$372K
2024 Q3
0 quarters
PAYC icon
199
Paycom
PAYC
$10.7B
$391K 0.1%
+2,350
New +$376K
2024 Q3
0 quarters
LLY icon
200
Eli Lilly
LLY
$1.04T
$377K 0.1%
425
– –
2023 Q3
4 quarters

Similar funds

Intellectus Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Intellectus Partners held 285 positions worth $391M, up 6.8% from $366M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Intellectus Partners's Q3 2024 filing shows 24 new, 110 increased, 87 reduced and 16 closed positions. Its largest new stake was Corcept Therapeutics: 54,859 shares worth $2.54M. The largest sale was KLA, an estimated $3.14M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Intellectus Partners's largest Q3 2024 buy was Corcept Therapeutics: 54,859 shares worth $2.54M.
  • Intellectus Partners added most to Snowflake in Q3 2024, an estimated $1.78M increase.
  • Intellectus Partners's biggest Q3 2024 reduction was KLA, cutting an estimated $3.14M.
  • Intellectus Partners fully exited Biogen in Q3 2024, selling an estimated $1.4M.
  • Intellectus Partners's ten largest holdings make up 24% of its $391M portfolio in Q3 2024.
  • Intellectus Partners opened 24 new positions and closed 16 in Q3 2024.
  • Intellectus Partners's portfolio value rose 6.8% quarter-over-quarter to $391M.

Based on Intellectus Partners's 13F filing for Q3 2024, filed 6 Nov 2024.